ClinVar Miner

Submissions for variant NM_001277115.2(DNAH11):c.6923C>T (p.Pro2308Leu)

gnomAD frequency: 0.00001  dbSNP: rs376475480
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000469872 SCV000551725 likely benign Primary ciliary dyskinesia 2024-10-29 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001160315 SCV001322106 uncertain significance Primary ciliary dyskinesia 7 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
GeneDx RCV002056712 SCV002496261 uncertain significance not provided 2024-11-04 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Ambry Genetics RCV000469872 SCV003866871 uncertain significance Primary ciliary dyskinesia 2023-03-01 criteria provided, single submitter clinical testing The c.6923C>T (p.P2308L) alteration is located in exon 42 (coding exon 42) of the DNAH11 gene. This alteration results from a C to T substitution at nucleotide position 6923, causing the proline (P) at amino acid position 2308 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV004737536 SCV005365874 uncertain significance DNAH11-related disorder 2024-08-07 no assertion criteria provided clinical testing The DNAH11 c.6923C>T variant is predicted to result in the amino acid substitution p.Pro2308Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0035% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.